Sodium Chloride Symporter Inhibitors

"Sodium Chloride Symporter Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Descriptor ID	D049993
MeSH Number(s)	D27.505.519.562.812 D27.505.696.560.500.863
Concept/Terms	Sodium Chloride Symporter Inhibitors Sodium Chloride Symporter Inhibitors Sodium Chloride Cotransporter Inhibitors Thiazide Sensitive NaCl Cotransporter Inhibitors Diuretics, Thiazide Diuretics, Thiazide Thiazide Diuretics Benzothiadiazine Diuretics Diuretics, Benzothiadiazine Potassium Depleting Diuretics Potassium Depleting Diuretics Diuretics, Potassium Depleting

Below are MeSH descriptors whose meaning is more general than "Sodium Chloride Symporter Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Sodium Chloride Symporter Inhibitors [D27.505.519.562.812]
Physiological Effects of Drugs [D27.505.696]
Natriuretic Agents [D27.505.696.560]
Diuretics [D27.505.696.560.500]
Sodium Chloride Symporter Inhibitors [D27.505.696.560.500.863]

Below are MeSH descriptors whose meaning is related to "Sodium Chloride Symporter Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Sodium Chloride Symporter Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Sodium Chloride Symporter Inhibitors" by people in this website by year, and whether "Sodium Chloride Symporter Inhibitors" was a major or minor topic of these publications.

Bar chart showing 3 publications over 2 distinct years, with a maximum of 2 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2018	2	0	2
2020	0	1	1

Below are the most recent publications written about "Sodium Chloride Symporter Inhibitors" by people in Profiles.

Bauer AZ, Gore R, Sama SR, Rosiello R, Garber L, Sundaresan D, McDonald A, Arruda P, Kriebel D. Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study. J Clin Hypertens (Greenwich). 2021 01; 23(1):21-27.

View in: PubMed
Singh S, Wang Z, Shahin MH, Langaee TY, Gong Y, Turner ST, Chapman AB, Gums JG, McDonough CW, Bailey KR, Beitelshees AL, Cooper-DeHoff RM, Scherer S, Boerwinkle E, Johnson JA. Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide. Pharmacogenet Genomics. 2018 11; 28(11):251-255.

View in: PubMed
Singh S, McDonough CW, Gong Y, Alghamdi WA, Arwood MJ, Bargal SA, Dumeny L, Li WY, Mehanna M, Stockard B, Yang G, de Oliveira FA, Fredette NC, Shahin MH, Bailey KR, Beitelshees AL, Boerwinkle E, Chapman AB, Gums JG, Turner ST, Cooper-DeHoff RM, Johnson JA. Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients. J Am Heart Assoc. 2018 03 09; 7(6).

View in: PubMed
Aslam F, Haque A, Agostini JV, Wang Y, Foody JM. Hypertension prevalence and prescribing trends in older US adults: 1999-2004. J Clin Hypertens (Greenwich). 2010 Feb 01; 12(2):75-81.

View in: PubMed
Kang DE, Maloney MM, Haleblian GE, Springhart WP, Honeycutt EF, Eisenstein EL, Marguet CG, Preminger GM. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol. 2007 May; 177(5):1785-8; discussion 1788-9.

View in: PubMed
Phillips RA. New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics. Arch Intern Med. 2006 Nov 13; 166(20):2174-6.

View in: PubMed
Przekop PR, Przekop A, Tulgan H. Subgroup demographic may have skewed ALLHAT results. J Am Osteopath Assoc. 2004 Feb; 104(2):70.

View in: PubMed
Rochon PA, Anderson GM, Tu JV, Gurwitz JH, Clark JP, Shear NH, Lau P. Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc. 1999 Aug; 47(8):954-9.

View in: PubMed
Rochon PA, Clark JP, Gurwitz JH. Challenges of prescribing low-dose drug therapy for older people. CMAJ. 1999 Apr 06; 160(7):1029-31.

View in: PubMed
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997 Oct 25; 315(7115):1096-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals